Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Goodwill & Intangibles (2024 - 2025)

Historic Goodwill & Intangibles for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to $142000.0.

  • Kairos Pharma's Goodwill & Intangibles changed N/A to $142000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $142000.0, marking a year-over-year change of. This contributed to the annual value of $222000.0 for FY2024, which is N/A changed from last year.
  • Kairos Pharma's Goodwill & Intangibles amounted to $142000.0 in Q2 2025.
  • Over the past 5 years, Kairos Pharma's Goodwill & Intangibles peaked at $262000.0 during Q3 2024, and registered a low of $142000.0 during Q2 2025.